ALK and neoplasm: The PD-L1 expression on tumor cells and tumor-infiltrating immune cells were further found to have no significance on prognosis when independently evaluated as factors, although the specific subset of ALK+ ALCL with both high tumor cell PD-L1 and high tumor environment immune cell PD-L1 yielded significantly lower 5-year PFS (177).